What Is Fluidless Underwriting? Programs That Are Working in 2026

Fluidless underwriting programs have quietly become the default path for most individual life insurance applications in the United States. The term itself still confuses people outside the industry — it simply means underwriting a life insurance policy without requiring blood or urine samples from the applicant. No nurse visit, no lab, no weeks of waiting. What replaced those fluids is a stack of electronic data sources and algorithmic risk scoring that, for a growing majority of applicants, produces mortality risk assessments that rival or match traditional lab-based evidence.

"Accelerated Underwriting has become a foundational component of most Individual Life programs, with 59% of applications eligible for an accelerated path in 2025, up from 42% in 2021." — Gen Re, U.S. Individual Life Next Gen Underwriting Survey (2025)

How fluidless underwriting programs actually work

The mechanics are straightforward, even if the data science behind them is not. When an applicant submits a life insurance application through a fluidless program, the carrier's system fires off requests to a dozen or more third-party data vendors simultaneously. Within seconds to minutes, it assembles a risk profile from prescription histories, motor vehicle records, credit-based insurance scores, MIB codes, criminal records, and increasingly, electronic health records pulled through FHIR-based APIs.

The underwriting engine scores this assembled profile against the carrier's risk models. If everything checks out — no red flags, face amount within program limits, applicant age within range — a decision can be rendered without a human underwriter ever looking at the case. Gen Re's 2025 survey found that roughly 12% of all individual life applications now go through a fully automated decisioning path. Another 47% qualify for accelerated review where a human underwriter still signs off but without requiring fluid evidence.

That leaves about 41% of applications still going through traditional underwriting. These are typically higher face amounts, older applicants, or cases where something in the electronic evidence triggers a need for clinical confirmation. Fluidless is not universal, and the carriers running successful programs are the ones who understand exactly where to draw that line.

Program component	What it replaces	How it works in practice
Prescription history (Rx databases)	Blood panel for cholesterol, diabetes markers	Milliman IntelliScript or ExamOne ScriptCheck pulls pharmacy benefit manager records showing all prescribed medications, dosages, and fill dates
Electronic health records (EHR)	Lab results from paramedical exam	FHIR-based APIs pull structured clinical data from provider systems, often including recent lab work the applicant already had done for routine care
MIB codes	Blood serology, prior medical history	MIB Group's database flags prior insurance applications that disclosed or revealed health conditions
Motor vehicle records	Behavioral risk assessment	Driving history correlates with mortality risk in actuarial models; DUIs and reckless driving are significant predictors
Credit-based insurance scores	General risk profiling	Where state regulation permits, credit behavior adds a behavioral dimension to the risk picture
Contactless camera-based vitals (rPPG)	Blood pressure reading at paramedical exam	Applicant takes a 30-second smartphone scan; camera captures heart rate and blood pressure signals through facial blood flow analysis
Application attestation + algorithms	Urine sample for nicotine/drugs	Self-reported status validated against Rx records, MIB data, and predictive models

Which carriers are running successful fluidless programs in 2026

Not every carrier's fluidless program performs equally. The gap between leaders and laggards is widening, and it comes down to data integration depth and algorithmic sophistication.

Pacific Life's Swift Sailing

Pacific Life's accelerated underwriting program, Swift Sailing, has become one of the more aggressive in the market. It offers coverage up to $3 million for nonsmokers and $2 million for nicotine users without requiring a medical exam. Eligibility extends to applicants up to age 60. The program pulls from multiple electronic data sources and can deliver decisions in days rather than weeks. Pacific Life reported that their accelerated path handles the majority of their individual term and universal life applications.

Protective Life

Protective has built its fluidless program around broad eligibility. Their no-exam offering covers applicants across a wide age and face amount range, and they've invested heavily in predictive analytics to expand who qualifies. The company's approach leans on combining traditional actuarial models with machine learning classifiers trained on their historical claims data.

The broader carrier landscape

According to Gen Re's 2024 U.S. Individual Life Accelerated Underwriting Survey, covering carriers representing over 2 million paid policies and $827 billion in face amount, 82% of participating carriers had either fully or partially implemented accelerated underwriting workflows. The survey showed an 86% placement rate for applications processed through automated workflows — better than the 75-85% historical range for traditional full underwriting. Speed matters: applicants who get a decision in hours are less likely to walk away than those waiting three weeks for a paramedical appointment.

The data sources making fluidless viable

This did not happen because of one big technology breakthrough. Several data ecosystems got good enough at roughly the same time, and carriers that figured out how to combine them pulled ahead.

Prescription databases remain the backbone. A statin prescription tells an underwriter about cardiovascular risk management. An insulin prescription reveals diabetes. Antidepressant fills signal mental health treatment. The medication history often surfaces conditions an applicant might not mention on an application, and it does so with timestamps that show treatment adherence over years.

Electronic health records are the next big piece falling into place. As health information exchanges expand and FHIR interoperability improves, carriers can access structured clinical data — including lab results from routine doctor visits — without ordering a separate insurance lab panel. If an applicant had a comprehensive metabolic panel done at their annual physical six months ago, that data is often sufficient for underwriting purposes.

Behavioral and public record data fills gaps that clinical data cannot. Motor vehicle records, credit history, and even social determinant data contribute to risk models that capture lifestyle factors traditional labs never could.

• Prescription history provides direct clinical evidence without invasive collection
• EHR integration eliminates redundant lab work by reusing existing clinical data
• Behavioral data captures risk dimensions that blood tests miss entirely
• Combining 15-30 data sources per application produces a more complete picture than the 3-5 sources in a traditional paramedical workflow

Current research and evidence

The actuarial evidence behind fluidless programs is solid at this point. Gen Re's research is the most comprehensive industry-wide dataset available, with their 2025 Next Gen Underwriting Survey covering a broad cross-section of U.S. individual life carriers.

Their findings show that the average time from application to final decision dropped to 5 days in accelerated paths versus 23 days in traditional full underwriting — a difference of 18 business days. For fully automated cases, decisions can come back in hours. That speed difference has real business consequences: the 86% placement rate in accelerated programs compared to historical traditional rates of 75-85% translates directly to revenue.

The Pacific Life 2026 Underwriting Outlook Survey, polling more than 100 industry leaders, found that 45% of life insurance executives report AI is already part of routine underwriting workflows. Electronic health records were rated as the data source expected to have the greatest impact on underwriting over the next three years.

Munich Re's ongoing mortality studies on fluidless cohorts have not shown adverse selection effects at the levels some actuaries feared. The early concerns — that removing labs would attract higher-risk applicants gaming the system — have not materialized at scale, largely because the electronic evidence nets cast wider than a single blood panel ever could.

The future of fluidless underwriting

Everything points toward broader eligibility and higher face amounts. Five years ago, most fluidless programs capped at $500,000. Today, Pacific Life's Swift Sailing goes to $3 million. The ceiling keeps rising because carriers are getting better at triangulating risk from non-fluid sources.

Three developments will likely accelerate this further:

Real-time biometric capture is adding a clinical dimension back into fluidless programs without the friction of a lab visit. Camera-based technologies using remote photoplethysmography (rPPG) can capture heart rate, blood pressure signals, and respiratory rate from a smartphone camera in under a minute. This gives underwriters a real-time physiological snapshot that complements the retrospective view provided by prescription histories and EHR data. Companies like Circadify are building this capability for insurance carrier integration.

Continuous underwriting will blur the line between initial risk assessment and ongoing policyholder monitoring. Instead of a single point-in-time evaluation, carriers will incorporate wearable data, periodic contactless scans, and updated EHR feeds to adjust risk profiles over the life of a policy. This model already exists in auto insurance (telematics-based pricing), and life insurance is heading in the same direction.

Regulatory alignment continues to evolve. State insurance departments have generally been supportive of accelerated underwriting, but questions around AI transparency, data privacy, and algorithmic fairness remain active. The NAIC's ongoing work on AI governance in insurance will shape how aggressively carriers can deploy automated decisioning.

Frequently asked questions

What does fluidless underwriting mean?

Fluidless underwriting is a life insurance underwriting approach that does not require blood or urine samples from the applicant. Instead of a paramedical exam and lab analysis, carriers use electronic data sources — prescription histories, electronic health records, motor vehicle records, credit-based scores, and other third-party data — to assess mortality risk and make underwriting decisions.

How much life insurance can you get without a medical exam in 2026?

Face amount limits have gone up a lot. Pacific Life's Swift Sailing program offers up to $3 million in coverage without a medical exam for qualifying nonsmokers. Other carriers have comparable limits depending on the applicant's age, health profile, and product type. Five years ago, most programs capped at $500,000 to $1 million.

Are fluidless underwriting decisions as accurate as traditional lab-based underwriting?

The actuarial evidence so far suggests comparable accuracy for the applicant populations that qualify. Gen Re's research shows an 86% placement rate for automated workflows, and ongoing mortality studies have not revealed significant adverse selection. The key is that fluidless programs use 15 to 30 data sources per application, compared to 3 to 5 in traditional workflows. The evidence volume is higher even though the evidence type is different.

Which carriers offer fluidless underwriting programs?

As of 2026, Gen Re's survey found that 82% of individual life carriers have fully or partially implemented accelerated underwriting programs. Major carriers with well-established fluidless offerings include Pacific Life (Swift Sailing), Protective Life, and numerous others. The industry has moved past the pilot phase — this is now standard practice for the majority of carriers.

For an analysis of how no-lab underwriting compares to traditional approaches and what data sources are replacing fluid evidence, see our post on No-Lab Life Insurance Underwriting: Is Fluidless the Future?.